FDA Drug recall D-1485-2014
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New…
- FDA Drug
- Class III
- terminated
- Published 2014-08-06
On 2014-08-06 the FDA classified a Class III recall of Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New… by Pfizer, citing failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1485-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-06-19 |
| Published | 2014-08-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pfizer |
| Distribution | US |
Product
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30
Reason
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Identifiers
| code_info | Lot # V130822; Exp 01/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1485-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.